Back to Authors

Geda, Yonas E

0000-0003-1187-7230

Mayo Clinic

Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.

Citations 110

Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years

International Journal of Geriatric Psychiatry | July 15, 2011 | Volume: 27 | Issue: 4 | Pages: 355-363

10.1002/gps.2713 | PMID 21744390

ObjectiveTo evaluate the degree to which longitudinal stability of subsyndromal symptoms of depression (SSD) is associated with conversion to dementia in patients with mild cognitive impairment (MCI).MethodsData from 405 MCI participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study were analyzed. Participants were evaluated at baseline and 12‐month intervals over 3 years. Participants were designated as MCI converters if dementia was diagnosed within 3 years or as cognitively stable MCI if dementia was not diagnosed during this interval. SSD were evaluated utilizing the 15‐item Geriatric Depression Scale (GDS). Endorsement of specific SSD at baseline and the stability of SSD over 36 months were compared between the two MCI groups.ResultsBaseline symptom endorsement and stability of total GDS scores did not differentiate MCI groups. Worsening of four individual items from the GDS over time (memory problems, feelings of helplessness, loss of interest, and preference for staying at home) differentiated MCI converters from cognitively stable MCI (p < 0.05 for all). However, only increased endorsement of memory symptoms over time was associated with progression to dementia after controlling for other clinical variables (p = 0.05).ConclusionsSSD in MCI participants largely consist of cognitive symptoms and activity limitations, and the stability of SSD over time differentiated the MCI groups better than baseline endorsement of symptoms. However, the only significant predictor of conversion to dementia was increased endorsement of memory problems, which likely represents insight into cognitive problems more than depressive symptomatology in MCI individuals. Copyright © 2011 John Wiley & Sons, Ltd.
Antidepressant Prescription Pattern in a Hospice Program

American Journal of Hospice and Palliative Medicine® | November 5, 2010 | Volume: 28 | Issue: 3 | Pages: 193-197

10.1177/1049909110385539 | PMID 21051782

Prevalence of treatable depression is as high as 25% among terminally ill patients. The incidence of antidepressant use was ascertained at the Mayo Hospice Program in Rochester, Minnesota, from June 1, 2007, to December 31, 2008. The 18-month cumulative probability to receive an antidepressant during hospice was estimated at 11.7%. Depression and selective serotonin reuptake inhibitors (SSRIs) were the most common clinical indication and class of antidepressant, respectively. Survival was the main predictor to receive an antidepressant with an odds ratio of 2.71 (95%CI: 1.60-4.60) for each additional day in hospice. Proper diagnostic tools for this population, education about the benefits of antidepressants in palliative care, and clear guidelines about antidepressant class and dosages are needed.
Untreated Type 2 Diabetes and Its Complications Are Associated With Subcortical Infarctions

Diabetes Care | October 28, 2010 | Volume: 34 | Issue: 1 | Pages: 184-186

10.2337/dc10-0602 | PMID 20980413

OBJECTIVE To investigate the association of type 2 diabetes with subcortical infarctions. RESEARCH DESIGN AND METHODS We investigated this association in subjects with type 2 diabetes (case subjects; n = 93) and without type 2 diabetes (control subjects; n = 186), matched by age, sex, and years of education. Participants were a subset of the Mayo Clinic Study of Aging (median age 79 years) who had undergone magnetic resonance imaging. RESULTS The frequency of subcortical infarctions was 39% in case subjects and 29% in control subjects (odds ratio 1.59 [95% CI 0.91–2.75]). The association was stronger in case subjects without treatment (2.60 [1.11–6.08]) and in case subjects with diabetes-related complications (1.96 [1.02–3.74]) compared with control subjects. CONCLUSIONS These findings suggest that untreated type 2 diabetes and type 2 diabetes with complications are associated with subcortical infarctions.
Pharmacogenomic Implications of Variants of Monoaminergic-Related Genes in Geriatric Psychiatry

Pharmacogenomics | September 22, 2010 | Volume: 11 | Issue: 9 | Pages: 1305-1330

10.2217/pgs.10.118 | PMID 20860469

Prevalence of mild cognitive impairment is higher in men

Neurology | September 6, 2010 | Volume: 75 | Issue: 10 | Pages: 889-897

10.1212/wnl.0b013e3181f11d85 | PMID 20820000

Novelty seeking and introversion do not predict the long-term risk of Parkinson disease

Neurology | July 26, 2010 | Volume: 75 | Issue: 4 | Pages: 349-357

10.1212/wnl.0b013e3181ea15fd | PMID 20660865

Blowing hot and cold over depression and cognitive impairment

Neurology | July 5, 2010 | Volume: 75 | Issue: 1 | Pages: 12-14

10.1212/wnl.0b013e3181e8cc2f | PMID 20603480

Association of C‐reactive protein with mild cognitive impairment

Alzheimer's & Dementia | September 13, 2009 | Volume: 5 | Issue: 5 | Pages: 398-405

10.1016/j.jalz.2009.01.025 | PMID 19751919

Background Inflammation is proposed to play a role in the development of Alzheimer's disease, and may also be involved in the pathogenesis of mild cognitive impairment (MCI). This study examined the association of inflammatory markers in serum or plasma with prevalent MCI and MCI subtypes in a population‐based sample. Methods Olmsted County, MN, residents aged 70–89 years on October 1, 2004, were evaluated using the Clinical Dementia Rating Scale, a neurological evaluation, and neuropsychological testing. Information ascertained for each participant was reviewed by an expert panel of neuropsychologists, physicians, and nurses, and a diagnosis of normal cognition, MCI, or dementia was made by consensus. C‐reactive protein (CRP), interleukin‐6 (IL‐6), tumor necrosis alpha (TNFα), and adiponectin were measured at baseline. Results Among 313 subjects with MCI and 1570 cognitively normal subjects, a CRP level in the upper quartile (>3.3 mg/L) was significantly associated with MCI (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.00–2.01) and with nonamnestic MCI (OR, 2.05; 95% CI, 1.12–3.78) after adjusting for age, sex, and years of education. However, there was no association with amnestic MCI (OR, 1.21; 95% CI, 0.81–1.82). No association was observed with the other inflammatory markers. Conclusions Plasma CRP is associated with prevalent MCI and with nonamnestic MCI in elderly, nondemented persons in a population‐based setting. These findings suggest the involvement of inflammation in the pathogenesis of MCI.
Long-Term Effects of Bilateral Oophorectomy on Brain Aging: Unanswered Questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging

Women's Health | January 16, 2009 | Volume: 5 | Issue: 1 | Pages: 39-48

10.2217/17455057.5.1.39 | PMID 19102639

In the Mayo Clinic Cohort Study of Oophorectomy and Aging, women who had both ovaries removed before reaching natural menopause experienced a long-term increased risk of parkinsonism, cognitive impairment or dementia, and depressive and anxiety symptoms. Here, we discuss five possible mechanistic interpretations of the observed associations; first, the associations may be non-causal because they result from the confounding effect of genetic variants or of other risk factors; second, the associations may be mediated by an abrupt reduction in levels of circulating estrogen; third, the associations may be mediated by an abrupt reduction in levels of circulating progesterone or testosterone; fourth, the associations may be mediated by an increased release of gonadotropins by the pituitary gland; and fifth, genetic variants may modify the hormonal effects of bilateral oophorectomy through simple or more complex interactions. Results from other studies are cited as evidence for or against each possible mechanism. These putative causal mechanisms are probably intertwined, and their clarification is a research priority.
Mortality in amnestic mild cognitive impairment

Neurology | November 28, 2006 | Volume: 67 | Issue: 10 | Pages: 1764-1768

10.1212/01.wnl.0000244430.39969.5f | PMID 17130407